SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-17-000347
Filing Date
2017-11-08
Accepted
2017-11-08 16:21:21
Documents
44
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDED SEPTEMBER 30, 2017 bivi-20170930_10q.htm 10-Q 286102
2 EXHIBIT 31.1 bivi-20170930_10qex31z1.htm EX-31.1 12106
3 EXHIBIT 32.1 bivi-20170930_10qex32z1.htm EX-32.1 5801
  Complete submission text file 0001520138-17-000347.txt   1738662

Data Files

Seq Description Document Type Size
4 XBRL DEFINITION FILE bivi-20170630_def.xml EX-101.DEF 33930
5 XBRL LABEL FILE bivi-20170630_lab.xml EX-101.LAB 147112
6 XBRL PRESENTATION FILE bivi-20170630_pre.xml EX-101.PRE 109314
7 XBRL SCHEMA FILE bivi-20170630.xsd EX-101.SCH 19146
8 XBRL INSTANCE FILE bivi-20170630.xml EX-101.INS 315922
9 XBRL CALCULATION FILE bivi-20170630_cal.xml EX-101.CAL 27182
Mailing Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915
Business Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915 312-283-5793
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55292 | Film No.: 171186841
SIC: 2834 Pharmaceutical Preparations